|
Current Clinical Trials by Principal Investigator
Clinical trials for the Institute are overseen by PeaceHealth's Institutional Review Board
Invasive Cardiology
|
|
| Chambers, Joseph M.D.; Cook, Stephen M.D.; Gory, Dennis M.D.; Hawn, Jerold M.D.; Lau, Samuel M.D.; Romm, Richard M.D. |
- JOMED JOSTENT Coronary Stent Graft (JOMED)
- Status: Active study, next review due on or before 9/7/2007
|
| Chambers, Joseph M.D.; Gory, Dennis M.D.; Hawn, Jerold M.D.; Lau, Samuel M.D.; Romm, Richard M.D. |
- TAXUS IV-SR: Treatment of De Novo Coronary Disease Using a Single Paclitaxel-Eluting Stent (Boston Scientific Corporation)
- Status: Active study, next review due on or before 9/7/2007
Investigational devices: TAXUS Paclitaxel-Eluting Coronary Stent System
IDE: G010274
|
| Chambers, Joseph M.D.; Cook, Stephen M.D.; Gory, Dennis M.D.; Hawn, Jerold M.D.; Lau, Samuel M.D.; Padgett, Richard M.D.; Romm, Richard M.D. |
- SPIRIT III Clinical Trial: A Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System in the Treatment of Subjects with de novo Native Coronary Artery Lesions (Guidant Corporation03-360)
- Status: Active study, next review due on or before 3/30/2007
Investigational devices: XIENCE V Everolimus Eluting Coronary Stent System
IDE: G050050
|
|
Lau, Samuel M.D.; Chambers, Joseph M.D.; Cook, Stephen M.D.; Gory, Dennis M.D.; Hawn, Jerold M.D.; Padgett, Richard M.D.; Romm, Richard M.D.
|
- HDE Amplatzer PFO Occluder (AGA Medical Corporation)
- Status: Active study, next review due on or before 6/2/2007
|
|
Lau, Samuel M.D.; Englander, Raymond M.D.
|
- Closure 1 Trial, A Prospective, Multicenter, Randomized Controlled Trial to Evaluate the Safety and Efficacy of the STARFlex Septal Closure System Versus Best Medical Therapy in Patients with a Stroke and/or Transient Ischemic Attack Due to Presumed Paradoxical Embolism Through A Patent Foramen Ovale (NMT Medical, Inc.)
- Status: Active study, next review due on or before 7/6/2007
- Investigational devices: STARFlex Septal Closure System
- IDE: FDA approved as an HDE
|
|
|
Pharmaceuticals
|
| Padgett, Richard M.D.; Chambers, Joseph M.D.; Cook, Stephen M.D.; Gory, Dennis M.D.; Hawn, Jerold M.D.; Lau, Samuel M.D. |
- A Comparison of CS-747 and Clopidogrel in Acute Coronary Syndrome Subjects who are to Undergo Percutaneous Coronary Intervention/TIMI-38 (Eli Lilly and CompanyH7T-MC-TAAL)
- Status: Active study, next review due on or before 11/2/2007
Investigational drugs: CS-747 (LY640315)
|
Pharmaceuticals with Invasive Cardiology Follow-up
|
|
|
Chambers, Joseph M.D.; Romm, Richard M.D.; Lau, Samuel M.D.; Cook, Stephen M.D.; Padgett, Richard M.D.; Gory, Dennis M.D.
|
- Clopidogrel Optimal Loading Dose Usage to Reduce Recurrent Events/Optimal Antiplatelet Strategy for Interventions - CURRENT/OASIS 7 (Sanofi-Aventis US Inc.EFC5965)
- Status: Active study, next review due on or before 2/1/2008
|
Cook, Stephen M.D.; Chambers, Joseph M.D.; Gory, Dennis M.D.; Hawn, Jerold M.D.; Lau, Samuel M.D.; Padgett, Richard M.D.
- Strategy to Reduce Atherosclerosis Development Involving Administration of Rimonabant - The Intravascular Ultrasound Study (STRADIVARIUS) (Sanofi-Aventis US Inc.EFC5827)
- Status: Active study, next review due on or before 11/30/2007
Investigational drugs: Rimonabant
- IND: 58-347
|
Electrophysiology
|
|
| Duke, David M.D.; McClelland, James M.D. |
- Thoracoscopically-Assisted Epicardial Bilateral Pulmonary Vein Isolation Using the Atricure Bipolar System and Exclusion of the Left Atrial Appendage for the Treatment of Atrial Fibrillation
(Atricure, Inc.CP2005-1)
- Status: Active study, next review due on or before 3/1/2008
|
| McClelland, James M.D.; Duke, David M.D.; Englander, Raymond M.D.; Ekstrom, Jon |
- Asymptomatic Cerebrovascular Accident and Left Atrial Function Following Minimally Invasive Surgery for Atrial Fibrillation Research Protocol
- Status: Approved pending revision, next review due on or before 4/5/2008
|
|
Reddy, Ramakota M.D.; McClelland, James M.D.
- Clinical Evaluation of Remote Notification to Reduce Time to Clinical Decision - CONNECT Study (Medtronic)
- Status: Active study, next review due on or before 2/1/2008
- Investigational devices: Concerto/Virtuoso family of ICDs and CRT-Ds, CareLink Programmer with Conexus Telemetry
- IDE: FDA approved
|
|
|
Back to OHVI Home
Oregon Heart & Vascular Institute
In Affiliation With Sacred Heart Medical Center
3311 RiverBend Drive, Springfield, OR 97477
email or phone: (541) 222-7218 or (888) 240-6484
|
|